- Home
- AMRN vs BSL Comparison
AMRN vs BSL Comparison
Compare AMRN & BSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$13.83
Company Overview
Basic Information| Metric | AMRN | BSL |
|---|---|---|
| Founded | 1989 | 2010 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 177.9M |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMRN | BSL |
|---|---|---|
| Price | $13.83 | $13.58 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 86.1K | 71.9K |
| Earning Date | 10-29-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.55% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $226,733,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.08 | $12.19 |
| 52 Week High | $20.90 | $14.56 |
Technical Indicators
Market Signals| Indicator | AMRN | BSL |
|---|---|---|
| Relative Strength Index (RSI) | 32.35 | 36.18 |
| Support Level | $13.41 | $13.50 |
| Resistance Level | $14.30 | $13.71 |
| Average True Range (ATR) | 0.75 | 0.07 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 8.80 | 28.57 |
Price Performance
Historical Comparison AMRN
BSL
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About BSL Blackstone
Blackstone Senior Floating Rate Term Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It also invests in second-lien loans and high yield bonds and employs financial leverage which may increase the risk to the Fund.